Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IPACK block for pain relief in advanced symptomatic knee osteoarthritis
RBR-56b7h3kPhase 2Completed
- Sponsor
- Programa de Pós-Graduação em Farmacologia (USP)
- Start
- May 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, triple-blind trial in knee osteoarthritis (OA) comparing Ropivacaine plus dexamethasone IPACK block with Dexamethasone IPACK block (2 arms). Started May 2022; status: completed.
02
Drugs
ropivacainedexamethasone
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on RBR-56b7h3k.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-56b7h3k.